XBiotech Inc (XBIT) — Capital Reinvestment Ratio

Latest as of December 2022: 0.05x

XBiotech Inc (XBIT) has a Capital Reinvestment Ratio of 0.05x as of December 2022, meaning it reinvests 0% of its operating cash flow ($2.70 Million) in capital expenditures ($132.00K). Check XBIT intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

$2.70 Million
USD

Capital Expenditures

$132.00K
USD

Data as of

Dec 2022
Most recent filing

XBiotech Inc Capital Reinvestment Ratio (2021–2021)

This chart tracks XBiotech Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see XBiotech Inc cash flow conversion.

Annual Capital Reinvestment Ratio for XBiotech Inc (2021–2021)

Year-by-year Capital Reinvestment Ratio for XBiotech Inc from 2021 to 2021. See XBIT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2021 0.05x $69.44 Million $3.52 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow